Hematological Abnormalities of Pulmonary Tuberculosis Patients with and without HIV at the University of Gondar Hospital, Northwest Ethiopia: A Comparative Cross-Sectional Study.

Tuberculosis Research and Treatment Pub Date : 2018-12-30 eCollection Date: 2018-01-01 DOI:10.1155/2018/5740951
Feven Abay, Aregawi Yalew, Agumas Shibabaw, Bamlaku Enawgaw
{"title":"Hematological Abnormalities of Pulmonary Tuberculosis Patients with and without HIV at the University of Gondar Hospital, Northwest Ethiopia: A Comparative Cross-Sectional Study.","authors":"Feven Abay,&nbsp;Aregawi Yalew,&nbsp;Agumas Shibabaw,&nbsp;Bamlaku Enawgaw","doi":"10.1155/2018/5740951","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hematological abnormalities are common in pulmonary tuberculosis (PTB) patients, which is one of the major public health problems worldwide. However, there is paucity of information about the hematological profile of PTB patients with and without HIV in the study area. Therefore, this study aimed to assess hematological abnormalities of pulmonary tuberculosis patients with and without HIV at the University of Gondar Hospital, Northwest Ethiopia.</p><p><strong>Methods: </strong>A comparative cross-sectional study was conducted at the University of Gondar Hospital. Sociodemographic data was collected using a pretested, structured questionnaire. Five milliliters of venous blood sample was collected and divided into a 3 ml EDTA tube for complete blood count with the Cell Dyn 1800 hematological analyzer and a 2 ml citrated tube for erythrocyte sedimentation rate determination. Data were entered into Epi Info version 3.5.3 and then transferred to SPSS 20 for analysis. The independent samples <i>t</i>-test was used to compare the mean values of hematological parameters between PTB patients and PTB-HIV coinfected patients.</p><p><strong>Result: </strong>A total of 100 study subjects (50 PTB and 50 PTB-HIV coinfected) were included with a mean age of 31.3 ± 10.3 years for PTB patients and 32.1 ± 9.2 years for PTB-HIV coinfected patients. In this study, there were significantly lower mean values of Hgb (<i>P</i> = 0.049), platelet count (<i>P</i> < 0.001), and neutrophils counts (<i>P</i> = 0.007) among PTB-HIV coinfected patients when compared with PTB patients. Of the PTB infected patients 46% were anemic, 6% leukopenic, 22% neutropenic, 8% lymphopenic, and 8% thrombocytopenic. On the other hand, of the PTB-HIV coinfected patients 60% were anemic, 14% leukopenic, 66% neutropenic, 12% lymphopenic, and 20% thrombocytopenic. ESR value was increased in all patients.</p><p><strong>Conclusion: </strong>This study demonstrated high prevalence of neutropenia, anemia, and thrombocytopenia among PTB-HIV coinfected patients. HIV coinfection worsens hematological abnormalities of PTB patients. Assessment of hematological parameters can be used as an indicator in the diagnosis and follow-up of PTB patients coinfected with HIV. We recommended assessment of PTB patients with or without HIV for various hematological disorders such as neutropenia, anemia, and thrombocytopenia.</p>","PeriodicalId":30261,"journal":{"name":"Tuberculosis Research and Treatment","volume":"2018 ","pages":"5740951"},"PeriodicalIF":0.0000,"publicationDate":"2018-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2018/5740951","citationCount":"31","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tuberculosis Research and Treatment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2018/5740951","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 31

Abstract

Background: Hematological abnormalities are common in pulmonary tuberculosis (PTB) patients, which is one of the major public health problems worldwide. However, there is paucity of information about the hematological profile of PTB patients with and without HIV in the study area. Therefore, this study aimed to assess hematological abnormalities of pulmonary tuberculosis patients with and without HIV at the University of Gondar Hospital, Northwest Ethiopia.

Methods: A comparative cross-sectional study was conducted at the University of Gondar Hospital. Sociodemographic data was collected using a pretested, structured questionnaire. Five milliliters of venous blood sample was collected and divided into a 3 ml EDTA tube for complete blood count with the Cell Dyn 1800 hematological analyzer and a 2 ml citrated tube for erythrocyte sedimentation rate determination. Data were entered into Epi Info version 3.5.3 and then transferred to SPSS 20 for analysis. The independent samples t-test was used to compare the mean values of hematological parameters between PTB patients and PTB-HIV coinfected patients.

Result: A total of 100 study subjects (50 PTB and 50 PTB-HIV coinfected) were included with a mean age of 31.3 ± 10.3 years for PTB patients and 32.1 ± 9.2 years for PTB-HIV coinfected patients. In this study, there were significantly lower mean values of Hgb (P = 0.049), platelet count (P < 0.001), and neutrophils counts (P = 0.007) among PTB-HIV coinfected patients when compared with PTB patients. Of the PTB infected patients 46% were anemic, 6% leukopenic, 22% neutropenic, 8% lymphopenic, and 8% thrombocytopenic. On the other hand, of the PTB-HIV coinfected patients 60% were anemic, 14% leukopenic, 66% neutropenic, 12% lymphopenic, and 20% thrombocytopenic. ESR value was increased in all patients.

Conclusion: This study demonstrated high prevalence of neutropenia, anemia, and thrombocytopenia among PTB-HIV coinfected patients. HIV coinfection worsens hematological abnormalities of PTB patients. Assessment of hematological parameters can be used as an indicator in the diagnosis and follow-up of PTB patients coinfected with HIV. We recommended assessment of PTB patients with or without HIV for various hematological disorders such as neutropenia, anemia, and thrombocytopenia.

Abstract Image

埃塞俄比亚西北部贡达尔大学医院肺结核患者伴和不伴HIV的血液学异常:一项比较横断面研究
背景:血液学异常在肺结核(PTB)患者中很常见,是世界范围内主要的公共卫生问题之一。然而,在研究地区,关于感染和不感染艾滋病毒的肺结核患者的血液学特征的信息缺乏。因此,本研究旨在评估埃塞俄比亚西北部贡达尔大学医院感染和不感染艾滋病毒的肺结核患者的血液学异常。方法:在贡达尔大学医院进行比较横断面研究。社会人口统计数据是通过预先测试的结构化问卷收集的。采集静脉血5毫升,分为3毫升EDTA管,用Cell Dyn 1800血液分析仪进行全血细胞计数,2毫升柠檬酸管,测定红细胞沉降率。数据输入Epi Info 3.5.3版本,然后转入SPSS 20进行分析。采用独立样本t检验比较PTB患者与PTB- hiv合并感染患者血液学参数的平均值。结果:共纳入100例研究对象,其中PTB患者50例,PTB合并感染患者50例,PTB合并感染患者平均年龄31.3±10.3岁,PTB合并感染患者平均年龄32.1±9.2岁。在本研究中,PTB- hiv合并感染患者的Hgb平均值(P = 0.049)、血小板计数平均值(P < 0.001)和中性粒细胞计数平均值(P = 0.007)明显低于PTB患者。PTB感染患者中46%为贫血,6%为白细胞减少,22%为中性粒细胞减少,8%为淋巴细胞减少,8%为血小板减少。另一方面,在PTB-HIV合并感染的患者中,60%为贫血,14%为白细胞减少,66%为中性粒细胞减少,12%为淋巴细胞减少,20%为血小板减少。所有患者的ESR值均升高。结论:本研究表明PTB-HIV合并感染患者中性粒细胞减少症、贫血和血小板减少症的患病率很高。HIV合并感染加重了肺结核患者的血液学异常。血液学指标的评估可作为肺结核合并HIV患者诊断和随访的指标。我们建议对合并或未合并HIV的肺结核患者进行各种血液学疾病的评估,如中性粒细胞减少症、贫血和血小板减少症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
6
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信